Prostate-specific antigen (PSA) alone is not an appropriate surrogate marker of long-term therapeutic benefit in prostate cancer trials

✍ Scribed by Laurence Collette; Tomasz Burzykowski; Fritz H. Schröder

• Book ID: 116428954
• Publisher: Elsevier Science
• Year: 2006
• Tongue: English
• Weight: 207 KB
• Volume: 42
• Category: Article
• ISSN: 0959-8049
• DOI: 10.1016/j.ejca.2006.02.011